用微信扫描二维码 分享至好友和朋友
经过评估，GMO小组得出结论，更新申请EFSA - GMO - RX - 016中没有证据表明有新的危害、修改后的暴露量以及科学不确定性会改变转基因玉米Bt11的原始风险评估结论、/div>
部分原文报道如下９/div>
Following the submission of application EFSA‐GMO‐RX?16 under Regulation (EC) No 1829/2003 from Syngenta the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the co
ntext of the renewal of authorisation application for the insect‐resistant and herbicide‐tolerant genetically modified maize Bt11, for food and feed uses, excluding cultivation within the European unio. The data received in the co
ntext of this renewal application co
ntained post‐market enviro
nmental mo
nitoring reports, a systematic search and e
valuation of literature, updated bioinformatic analyses, and additio
nal docu
ments or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the co
ntext of the original application. Under the assumption that the DNA sequences of the event in maize Bt11 co
nsidered for renewal is identical to the sequence of the originally assessed events, the GMO Panel co
ncludes that there is no evidence in renewal application EFSA‐GMO‐RX?16 for new hazards, modified exposure or scientific uncertainties that would change the co
nclusions of the original risk assessment on maize Bt11.
- 下一篇：韩国消费者联盟对国会议员进行转基因生物体认知调查
- 上一篇：
鲁公网安 37060202000128叶/a>